Up a level |
Corrie, PG, Marshall, A, Nathan, PD, Lorigan, P, Gore, M, Tahir, S, Faust, G, Kelly, CG, Marples, M, Danson, SJ et al (show 28 more authors)
(2019)
Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial (vol 29, pg 1843, 2018).
ANNALS OF ONCOLOGY, 30 (12).
pp. 2013-2014.
Cheung, VTF, Gupta, T, Olsson-Brown, A, Subramanian, S ORCID: 0000-0002-6483-1730, Sasson, SC, Heseltine, J, Fryer, E, Collantes, E, Sacco, JJ, Pirmohamed, M ORCID: 0000-0002-7534-7266 et al (show 6 more authors)
(2020)
Immune checkpoint inhibitor-related colitis assessment and prognosis: can inflammatory bowel disease scoring point the way?
.